このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

AI を使用して検出された歯周炎を伴う歯髄炎のある臼歯と歯周炎のない臼歯の歯髄切除の成功

2026年7月12日 更新者:Marwan Sherif ElSefsafy Ibrahim、Misr International University

人工知能を使用して検出された根尖性歯周炎を伴う不可逆性歯髄炎を伴う成熟永久臼歯と根尖性歯周炎のない成人永久臼歯の全歯髄切除の成功率:ランダム化比較試験

Statement of problem: Although performing full pulpotomy in mature permanent molars with irreversible pulpitis showed success rates comparable to RCT, there is a growing need for further studies in order to determine the predictability of pulpotomy in teeth with apical periodontitis. Aim of the study: The aim of this study is to compare the success rates in cases of moderate pulpitis without apical periodontitis in comparison to cases of severe pulpitis with AI-Detected apical periodontitis. Additionally, the study aims to evaluate the accuracy of a novel AI technology in identifying apical periodontitis from radiographs, comparing its findings to the operator's radiographical and clinical observations. Subjects and methods: Patients with mature permanent molars diagnosed with irreversible pulpitis will be selected. The teeth will be divided according to the presence or absence of apical periodontitis into 2 groups. The first group being moderate pulpitis without apical periodontitis to be treated with full pulpotomy and the second group being severe pulpitis with apical periodontitis to be treated with full pulpotomy. Finally, a third control group of teeth with irreversible pulpitis to be treated with conventional root canal treatment will be added. An artificial intelligence software will process the preoperative radiographs to detect the presence of apical periodontitis, and its accuracy will be compared to the blinded operator using clinical and radiographic methods. The patients will be randomly allocated to receive either full pulpotomy or conventional root canal treatment. Full pulpotomy using MTA will be performed for groups 1 and 2, and a final restoration will be placed. While group 3 will receive conventional root canal treatment and a final restoration. Cases will be followed up after 1, 3, and 6 months respectively to assess the clinical and radiographic success.

調査の概要

詳細な説明

The dental pulp constitutes a distinct and intricate entity susceptible to various thermal, traumatic, microbial, and chemical stimuli. (1) As a result, the dentin-pulp complex experiences a sophisticated immune response, leading to the recruitment of immune cells and inflammation of dental pulp cells at the local level. (2,3,4) Historically, in instances of irreversible pulpitis, the conventional recommendation has been root canal treatment (RCT), based on the belief that the pulp lacked the ability to undergo recovery. (5,6)

Vital pulp therapy (VPT) is an approach focused on minimally invasive measures, aiming to seal the pulpal wound with a bioactive substance subsequent to the removal of infected pulpal tissues. (7,8) Procedures associated with VPT encompass direct and indirect pulp capping, partial pulpotomy, and full pulpotomy. (9) Typically, VPT interventions are carried out to safeguard the radicular pulp in both deciduous and adult immature teeth. (10,11) In accordance with the position statements released by the American Association of Endodontists (AAE) in 2021 and the European Society of Endodontology (ESE) in 2019, full and partial pulpotomy emerge as promising and more conservative alternatives to root canal treatment for managing mature permanent teeth afflicted with irreversible pulpitis and cariously exposed pulps. (10,12) This is also backed by literature since a lot of researches shows that performing full pulpotomy to manage mature permanent molars with irreversible pulpitis is highly successful. (30,31,32,33)

A full pulpotomy entails the complete removal of coronal pulp tissues, succeeded by the application of a biomaterial onto the remaining tissues at the root canal orifices. (12) The utilization of pulpotomy preserves the pulp mechanoreceptors, along with its defensive and developmental functions, including the formation of primary and secondary dentin.(12) Furthermore, pulpotomies are characterized by being less time-consuming, less invasive, and less intricate when compared to root canal treatment. Over the past two decades, numerous studies have indicated that pulpotomy can serve as an effective alternative to root canal treatment for managing irreversible pulpitis in mature permanent teeth.(13,14)

The AAE classification simplifies pulpitis into reversible and irreversible categories. However, the term "irreversible" is questioned as histological evidence shows no clear boundary for irreparability. In 2017, a new classification proposed by Wolters et al (15) eliminated the term "irreversible" and linked symptoms to VPT management strategies. Subsequent research by Careddu and Duncan in 2021 supported the new classification's potential prognostic benefit in partial pulpotomy.

Wolter's classification mainly entitles the following:

  1. Initial Pulpitis:

    A heightened but not prolonged response to the cold test, insensitivity to percussion, and an absence of spontaneous pain. (15)

  2. Mild Pulpitis:

    An intensified and extended reaction to cold, warm, and sweet stimuli lasting up to 20 seconds, potentially percussion-sensitive. Histologically, this suggests limited local inflammation confined to the crown pulp. (15)

  3. Moderate Pulpitis:

    Evident symptoms, strong, heightened, and prolonged response to cold which can last up to several minutes, potentially percussion-sensitive, and spontaneous dull pain that can be partially or completely alleviated with pain medication. Histologically, this indicates extensive local inflammation confined to the crown pulp. (15)

  4. Severe Pulpitis:

Severe spontaneous pain and distinct pain response to warm and cold stimuli, often sharp to throbbing, causing difficulty sleeping (exacerbated when lying down). Tooth sensitivity to touch and percussion is pronounced. Histologically, this suggests extensive local inflammation in the crown pulp, possibly extending into the root canals. (15)

Wolter et al indicated that initial and mild pulpitis will only require indirect pulp therapy. (15)

Traditionally, it was hypothesized that a tooth with a periapical radiolucency has a necrotic, infected pulp space. Thus, root canal treatment was the treatment of choice for these teeth.(2) However, it was proven that even in the presence of a large periapical radiolucency, portions of the radicular pulp tissues can maintain their vitality.(3) This suggests that in cases with apical periodontitis, if vital pulp tissues are evident after pulp exposure, pulpotomy can be a viable alternative treatment modality to root canal treatment.(4)

In 2018, Taha et al. aimed to evaluate the outcome of full pulpotomy in mature permanent teeth using Biodentine. Eight of the cases exhibited preoperative periapical rarefaction, and seven of them showed improvement in the periapical index score. Similarly, in a 2016 randomized clinical trial, all of the seven cases with preoperative periapical radiolucencies showed complete resolution of the lesions at the end of the study.(5) Other earlier studies also reported success of pulpotomy procedures in cases with periapical involvement. (34,35,36) However, there is a growing need for further studies in order to determine the predictability of pulpotomy in teeth with apical radiolucencies, and to detect features that can act as negative prognostic factors in these cases.(4)

In 2013, the American Association of Endodontists classified the diagnosis of periapical condition into normal apical tissues, symptomatic apical periodontitis, asymptomatic apical periodontitis, chronic apical abscess, acute apical abscess, and condensing osteitis. The term "apical periodontitis" indicates that the apical periodontal tissues are inflamed. In symptomatic apical periodontitis, the tooth has a painful reaction to palpation, percussion, and biting. Radiographically, the tooth may have a normal periodontium or a periapical radiolucency depending on the stage of the periapical disease. On the other hand, teeth with asymptomatic apical periodontitis do not exhibit pain on palpation or percussion, and they are associated with a periapical radiolucency in the radiograph.(1)

It is well-recognized that the effectiveness of detecting radiographic apical periodontitis is contingent upon the proficiency of the operator(16). Therefore, it has become imperative to develop or employ Artificial Intelligence (AI)-based software solutions that can accurately diagnose periapical radiolucencies. Artificial intelligence (AI) is designed to mimic human intelligence and address specific challenges. AI contributes to the creation of algorithms that can learn from provided information and make predictions. Machine learning, a subset of AI, constructs algorithms based on data.(17) Among the earliest AI algorithms were neural networks (NNs). Deep learning neural networks are complex structures with multiple layers, while shallow learning neural networks are simpler with fewer layers. Convolutional neural networks (CNNs) are primarily used for analyzing intricate images.(17)

AI technology has arisen as a response to the need for machines to emulate human intelligence, facilitating the provision of more standardized results.(18) For instance, AI-enabled imaging applications in the medical domain exhibit autonomous object detection and image classification capabilities, with numerous studies demonstrating remarkable accuracy and promise in diagnosing pathologies(19), interpreting radiological data(20), and assessing dermatological conditions(21).

From a dental perspective, AI applications can be stratified into several domains, encompassing diagnosis, decision support, treatment planning, and prognosis prediction, with diagnostic capabilities being particularly prominent. AI stands poised to augment diagnostic precision and efficiency, thereby alleviating the professional burden on dentists, who increasingly rely on computerized decision support systems.(18)

Within the realm of endodontics, Anita Aminoshariae et al in 2021 mentioned that AI can currently assist in detection of peri-apical lesions, crown and root fractures, working length determination and even the morphology of root canals and the root canal systems.(23) A systematic review by Agata Ossowska et al in 2022 concluded that AI can also be used in predicting the ability of dental pulp stem cells to survive in some treatments and predicting the success of re-treatment of a failed root canal therapy (RCT).(24) However, it's important to note that AI tended to over-detect lesions while human operators tended to under-detect them.(22)

Duncan et al, in 2022, recommended the use of CBCT as it can detect periapical lesions better than 2-Dimensional X-Rays.(4)In another review by Issa et al in 2023, AI has exhibited an exceptional level of precision in detecting apical periodontitis within periapical radiographs, owing to its capacity to detect intricate patterns and attributes beyond the detection of human observation.(6)

This, in turn, positions it as an efficient auxiliary diagnostic instrument for dental professionals, simultaneously mitigating the clinical burden and improving the standard of care.(6)

The main goal of this research is to compare cases of moderate pulpitis without apical periodontitis in comparison to cases of severe pulpitis with AI-Detected apical periodontitis. Additionally, the study aims to evaluate the accuracy of a novel AI technology in identifying apical periodontitis from radiographs and to establish the correlation between the utility of AI as a dependable supplementary tool in the decision-making process when contemplating full pulpotomy for mature permanent molars.

In the paper by Duncan et al, even though it was proven that even in the presence of a large periapical radiolucency, portions of the radicular pulp tissues can maintain their vitality, more clinical studies are needed to assess the success rates of cases with severe irreversible pulpitis with apical periodontitis.

The study done by Anita Aminoshariae et al reported that AI can accurately detect peri-apical lesions. However, another study by Cantu et al reported that AI generally tends to over-detect lesions. Thus, it is imperative to compare AI findings to the operator's radiographical observations.

研究の種類

介入

入学 (実際)

57

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Obour
      • Cairo、Obour、エジプト、23726.
        • Misr International University

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

20年~45年 (大人)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Presence of vital mature permanent molars diagnosed as severe irreversible pulpitis with apical periodontitis diagnosed clinically and radiographically and cases diagnosed as moderate irreversible pulpitis without apical periodontitis diagnosed clinically and radiographically per Wolter's classification.
  • Participants of both genders falling within the age range of 20 to 45 years.
  • Confirmation of vital bleeding pulp tissue in all canals following complete pulpotomy.

Exclusion Criteria:

  • Non-vital tooth
  • Moderate pulpitis with apical periodontitis
  • Teeth with Immature roots
  • Uncontrolled pulpal bleeding persisting beyond 10 minutes post-application of sodium hypochlorite as a hemostatic agent.
  • Insufficient bleeding post-pulp exposure, indicative of pulp degeneration.
  • Cases categorized as initial and mild pulpitis per Wolter's classification.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Teeth with moderate pulpitis without Apical Periodontitis

Teeth with moderate pulpitis without Apical Periodontitis to be treated with full pulpotomy

Patients with mature permanent molars diagnosed with moderate pulpitis without apical periodontitis to be treated with full pulpotomy.

実験的:Teeth with severe pulpitis with Apical Periodontitis

Teeth with severe pulpitis with Apical Periodontitis to be treated with full pulpotomy

Patients with mature permanent molars diagnosed with severe pulpitis with apical periodontitis to be treated with full pulpotomy.

アクティブコンパレータ:Teeth with irreversible pulpitis

Teeth with irreversible pulpitis treated with Conventional root canal treatment.

Teeth with irreversible pulpitis to be treated with conventional root canal treatment

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Clinical and Radiographic Treatment Success at 6 Months
時間枠:6 months after treatment

Treatment success was assessed clinically and radiographically. Clinical success was defined as absence of spontaneous pain, pain on percussion or palpation, swelling, sinus tract, pathological mobility, or other signs of endodontic failure. Radiographic success was defined as absence, reduction, or non-progression of periapical pathology on follow-up periapical radiographs.

6 months after treatment

二次結果の測定

結果測定
メジャーの説明
時間枠
Agreement Between AI-based Radiographic Assessment and Clinical Percussion-based Findings and Examiner-based Radiographic Assessment of Apical Periodontitis
時間枠:6 months

AI-based radiographic assessment of apical periodontitis was compared with clinical percussion-based findings and examiner-based radiographic assessment on periapical radiographs. Agreement between assessment methods was evaluated using Fleiss's Kappa, and differences between methods were assessed using Cochran's Q test and Friedman's test.

6 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年11月3日

一次修了 (実際)

2025年8月30日

研究の完了 (実際)

2025年8月30日

試験登録日

最初に提出

2024年11月3日

QC基準を満たした最初の提出物

2025年1月5日

最初の投稿 (実際)

2025年1月9日

学習記録の更新

投稿された最後の更新 (実際)

2026年10月5日

QC基準を満たした最後の更新が送信されました

2026年7月12日

最終確認日

2026年7月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

De-identified individual participant data underlying the results reported in this article will be made available upon reasonable request. Shared data may include baseline demographic and clinical data, treatment group allocation, follow-up status, clinical and radiographic outcome data, and AI/examiner assessment data. No directly identifiable participant information will be shared. Access will be subject to approval by the corresponding author and the institutional requirements of Misr International University.

IPD 共有時間枠

Data and supporting information will be available beginning 6 months after publication and for 5 years after publication.

IPD 共有アクセス基準

Data will be available to researchers who submit a scientifically sound proposal to the corresponding author. Requests will be reviewed by the corresponding author and may require approval from Misr International University. Data will be shared for academic and research purposes only, after approval of the request and, when required, completion of a data-sharing agreement.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する